Potential mechanisms for astrocyte-TIMP-1 downregulation in chronic inflammatory diseases

Journal of Neuroscience Research

Volumn 83, Issue 7, 2006, Pages 1281-1292

  Gardner, Jessica ^a   Borgmann, Kathleen ^a   Deshpande, Muralidhar S ^a   Dhar, Alok ^a   Wu, Li ^a   Persidsky, Raisa ^a   Ghorpade, Anuja ^a,b,c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c 985215 Nebraska Medical Center   (United States)

Author keywords

HIV 1; IL 1 ; Neurodegenerative disorders; TIMP 1

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; MATRILYSIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; ASTROCYTE; ASTROCYTOMA; CELL ACTIVATION; CELL DEATH; CHRONIC INFLAMMATION; DEGENERATIVE DISEASE; DEMENTIA; DOWN REGULATION; ENZYME ACTIVATION; ENZYME BINDING; ENZYME REGULATION; EPILEPSY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA STABILITY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANTIGENS, CD95; ASTROCYTES; CELL LINE, TUMOR; CELLS, CULTURED; DOWN-REGULATION; ENCEPHALITIS; EXTRACELLULAR MATRIX; HUMANS; INTERLEUKIN-1; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RECEPTORS, INTERLEUKIN-1; REGULATORY ELEMENTS, TRANSCRIPTIONAL; RNA STABILITY; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANS-ACTIVATION (GENETICS);

EID: 33646337422     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.20823     Document Type: Article

References (52)

1. Bottner M, Krieglstein K, Unsicker K. 2000. The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions. J Neurochem 75:2227-2240.
2. Boutin H, Kimber I, Rothwell NJ, Pinteaux E. 2003. The expanding interleukin-1 family and its receptors: do alternative IL-1 receptor/signaling pathways exist in the brain? Mol Neurobiol 27:239-248.
3. Brew K, Dinakarpandian D, Nagase H. 2000. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477:267-283.
4. Bullen EC, Longaker MT, Updike DL, Benton R, Ladin D, Hou Z, Howard EW. 1995. Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol 104:236-240.
5. Canki M, Thai JN, Chao W, Ghorpade A, Potash MJ, Volsky DJ. 2001. Highly productive infection with pseudotyped human immunodeficiency virus type 1 (hiv-1) indicates no intracellular restrictions to hiv-1 replication in primary human astrocytes. J Virol 75:7925-7933.
6. Chadderton T, Wilson C, Bewick M, Gluck S. 1997. Evaluation of three rapid RNA extraction reagents: relevance for use in RT-PCRs and measurement of low level gene expression in clinical samples. Cell Mol Biol (Noisy-le-grand) 43:1227-1234.
7. Clark IM, Rowan AD, Edwards DR, Bech-Hansen T, Mann DA, Bahr MJ, Cawston TE. 1997. Transcriptional activity of the human tissue inhibitor of metalloproteinases 1 (TIMP-1) gene in fibroblasts involves elements in the promoter, exon 1 and intron 1. Biochem J 324:611-617.
8. Crocker SJ, Pagenstecher A, Campbell IL. 2004. The TIMPs tango with MMPs and more in the central nervous system. J Neurosci Res 75:1-11.
9. da Cunha A, Jefferson JA, Jackson RW, Vitkovic L. 1993. Glial cell-specific mechanisms of TGF-beta 1 induction by IL-1 in cerebral cortex. J Neuroimmunol 42:71-85.
10. Deb S, Zhang JW, Gottschall PE. 1999. Activated isoforms of MMP-2 are induced in U87 human glioma cells in response to beta-amyloid peptide. J Neurosci Res 55:44-53.
11. Dhar A, Gardner J, Borgmann K, Wu L, Ghorpade A. 2006. A novel role of TGF-beta in differential astrocyte-TIMP-1 regulation: Implications for HIV-1-dementia and neuroinflammation. J Neurosci Res 83:1271-1280.
12. Doyle GA, Saanalho-Kere UK, Parks WC. 1997. Distinct mechanisms regulate TIMP-1 expression at different stages of phorbol ester-mediated differentiation of U937 cells. Biochemistry 36:2492-2500.
13. Gardner J, Ghorpade A. 2003. Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system. J Neurosci Res 74:801-806.
14. Ghorpade A, Holter S, Borgmann K, Persidsky R, Wu L. 2003. HIV-1 and IL-1beta regulate Fas ligand expression in human astrocytes through the NF-kappaB pathway. J Neuroimmunol 141:141-149.
15. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. 1997. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74:111-122.
16. Gottschall PE, Deb S. 1996. Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. Neuroimmunomodulation 3:69-75.
17. Guo CJ, Douglas SD, Gao Z, Wolf BA, Grinspan J, Lai JP, Riedel E, Ho WZ. 2004. Interleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes. Glia 48:259-266.
18. Hall MC, Young DA, Waters JG, Rowan AD, Chantry A, Edwards DR, Clark IM. 2003. The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-beta 1. J Biol Chem 278:10304-10313.
19. Han R, Smith TJ. 2005. Induction by IL-1 beta of tissue inhibitor of metalloproteinase-1 in human orbital fibroblasts: modulation of gene promoter activity by IL-4 and IFN-gamma. J Immunol 174:3072-3079.
20. Jaworski J, Biedermann IW, Lapinska J, Szklarczyk A, Figiel I, Konopka D, Nowicka D, Filipkowski RK, Hetman M, Kowalczyk A, Kaczmarek L. 1999. Neuronal excitation-driven and AP-1-dependent activation of tissue inhibitor of metalloproteinases-1 gene expression in rodent hippocampus. J Biol Chem 274:28106-28112.
21. Kim SY, Ahn BH, Min KJ, Lee YH, Joe EH, Min do S. 2004. Phospholipase D isozymes mediate epigallocatechin gallate-induced cyclooxygenase-2 expression in astrocyte cells. J Biol Chem 279:38125-38133.
22. Kintscher U, Kon D, Wakino S, Goetze S, Graf K, Fleck E, Hsueh WA, Law RE. 2001. Doxazosin inhibits monocyte chemotactic protein 1-directed migration of human monocytes. J Cardiovasc Pharmacol 37:532-539.
23. Kuzhikandathil EV, Molloy GR. 1994. Transcription of the brain creacine kinase gene in glial cells is modulated by cyclic AMP-dependent protein kinase. J Neurosci Res 39:70-82.
24. Li J, Liu Y, Park IW, He JJ. 2002. Expression of exogenous Sam68, the 68-kilodalton SRC-associated protein in mitosis, is able to alleviate impaired Rev function in astrocytes. J Virol 76:4526-4535.
25. Li YY, Feldman AM, Sun Y, McTiernan CF. 1998. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation 98:1728-1734.
26. Liu Y, Liu H, Kim BO, Gattone VH, Li J, Nath A, Blum J, He JJ. 2004. CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J Virol 78:4120-4133.
27. Lopez-Herrera A, Liu Y, Rugeles MT, He JJ. 2005. HIV-1 interaction with human mannose receptor (hMR) induces production of matrix metalloproteinase 2 (MMP-2) through hMR-mediated intracellular signaling in astrocytes. Biochim Biophys Acta 1741:55-64.
28. Mannello F, Gazzanelli G. 2001. Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implications. Apoptosis 6:479-482.
29. Manthrope M, Fagnani R, Skaper SD, Varon S. 1986. An automated colorimetric microassay for neurotrophic factors. Dev Brain Res 25:191-198.
30. Morganti-Kossmann MC, Kossmann T, Brandes ME, Mergenhagen SE, Wahl SM. 1992. Autocnne and paracrine regulation of astrocyte function by transforming growth factor-beta. J Neuroimmunol 39:163-173.
31. Mullner EW, Kuhn LC. 1988. A stem-loop in the 3′ untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm. Cell 53:815-825.
32. Nagase H, Meng Q, Malinovskii V, Huang W, Chung L, Bode W, Maskos K, Brew K. 1999. Engineering of selective TIMPs. Ann NY Acad Sci 878:1-11.
33. Nguyen M, Arkell J, Jackson CJ. 2001. Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol 33:960-970.
34. Pagenstecher A, Stalder AK, Kincaid CL, Shapiro SD, Campbell IL. 1998. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol 152:729-741.
35. Peltz SW, Brewer G, Bernstein P, Hart PA, Ross J. 1991. Regulation of mRNA turnover in eukaryotic cells. Crit Rev Eukaryot Gene Expr 1: 99-126.
36. Persidsky Y, Ghorpade A, Rasmussen J, Limoges J, Liu XJ, Stins M, Fiala M, Way D, Kim KS, Witte MH, Weinand M, Carhart L, Gendelman HE. 1999. Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Am J Pathol 155:1599-1611.
37. Pontecorvi A, Tata JR, Phyillaier M, Robbins J. 1988. Selective degradation of mRNA: the role of short-lived proteins in differential destabilization of insulin-induced creatine phosphokinase and myosin heavy chain mRNAs during rat skeletal muscle L6 cell differentiation. EMBO J 7:1489-1495.
38. Pousset F, Cremona S, Dantzer R, Kelley KW, Parnet P. 2001. IL-10 and IL-4 regulate type-I and type-II IL-1 receptors expression on IL-1 beta-activated mouse primary astrocytes. J Neurochem 79:726-736.
39. Rasty S, Thatikunta P, Gordon J, Khalili K, Amini S, Glorioso JC. 1996. Human immunodeficiency virus tat gene transfer to the murine central nervous system using a replication-defective herpes simplex virus vector stimulates transforming growth factor beta 1 gene expression. Proc Natl Acad Sci USA 93:6073-6078.
40. Schwartz ML, Shneidman PS, Bruce J, Schlaepfer WW. 1992. Actinomycin prevents the destabilizatton of neurofilament mRNA in primary sensory neurons. J Biol Chem 267:24596-24600.
41. Seo DW, Li H, Guedez L, Wingfield PT, Diaz T, Salloum R, Wei BY, Stetler-Stevenson WG. 2003. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell 114:171-180.
42. Speth C, Joebstl B, Barcova M, Dierich MP. 2000. HIV-1 envelope protein gp41 modulates expression of interleukin-10 and chemokine receptors on monocytes, astrocytes and neurones. AIDS 14:629-636.
43. Steinberg RA, Levinson BB, Tomkins GM. 1975. "Superinduction" of tyrosine aminotransferase by actinomycin D: a reevaluation. Cell 5:29-35.
44. Suryadevara R, Holter S, Borgmann K, Persidsky R, Labenz-Zink C, Persidsky Y, Gendelman HE, Wu L, Ghorpade A. 2003. Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: links to HIV-1 dementia. Glia 44:47-56.
45. Tan HK, Heywood D, Ralph GS, Bienemann A, Baker AH, Uney JB. 2003. Tissue inhibitor of metalloproteinase 1 inhibits excitotoxic cell death in neurons. Mol Cell Neurosci 22:98-106.
46. Touzani O, Boutin H, Chuquet J, Rothwell N. 1999. Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. J Neuroimmunol 100:203-215.
47. VanMeter TE, Rooprai HK, Kibble MM, Fillmore HL, Broaddus WC, Pilkington GJ. 2001. The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis. J Neurooncol 53:213-235.
48. Vitkovic L, Bockaert J, Jacque C. 2000. "Inflammatory" cytokines: neuromodulators in normal brain? J Neurochem 74:457-471.
49. Yang EV, Bane CM, MacCallum RC, Kiecolt-Glaser JK, Malarkey WB, Glaser R. 2002. Stress-related modulation of matrix metalloproteinase expression. J Neuroimmunol 133:144-150.
50. Young DA, Billingham O, Sampieri CL, Edwards DR, Clark IM. 2005. Differential effects of histone deacetylase inhibitors on phorbol ester-and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression. FEBS J 272:1912-1926.
51. Yun SJ, Kim MO, Kim SO, Park J, Kwon YK, Kim IS, Lee EH. 2002. Induction of TGF-beta-inducible gene-h3 (betaig-h3) by TGF-beta1 in astrocytes: implications for astrocyte response to brain injury. Brain Res Mol Brain Res 107:57-64.
52. Zelenaia OA, Robinson MB. 2000. Degradation of glial glutamate transporter mRNAs is selectively blocked by inhibition of cellular transcription. J Neurochem 75:2252-2258.